Does Quidel Corporation (QDEL) Have More Gas After Achieving 52-Week High?

April 18, 2018 - By Clifton Ray

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.03, from 1.2 in 2017Q3. It dropped, as 18 investors sold Quidel Corporation shares while 35 reduced holdings. 27 funds opened positions while 35 raised stakes. 30.94 million shares or 0.83% more from 30.68 million shares in 2017Q3 were reported.
Grp One Trading L P has 0% invested in Quidel Corporation (NASDAQ:QDEL) for 4,000 shares. Acadian Asset Limited Liability Corporation accumulated 7,671 shares. Los Angeles Capital And Equity holds 10,620 shares or 0% of its portfolio. Millennium Mgmt Limited Com holds 0.03% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 579,709 shares. Moreover, Ameritas Investment Prns has 0% invested in Quidel Corporation (NASDAQ:QDEL) for 2,221 shares. 1.13M are held by Macquarie Gp. York Capital Mgmt Advisors Ltd Limited Liability Company owns 120,371 shares. Swiss Savings Bank has invested 0% in Quidel Corporation (NASDAQ:QDEL). Wellington Mgmt Gru Ltd Liability Partnership holds 46,503 shares or 0% of its portfolio. 86,452 are owned by Morgan Stanley. Amer Intll Group Inc owns 19,141 shares for 0% of their portfolio. Parallax Volatility Advisers Lp stated it has 4,242 shares or 0% of all its holdings. Inv Mgmt Of Virginia Ltd Liability Corp has invested 1.87% in Quidel Corporation (NASDAQ:QDEL). Cannell Peter B & Inc has 408,800 shares for 0.61% of their portfolio. Tower Rech Ltd Limited Liability Company (Trc) owns 199 shares.

Since October 27, 2017, it had 0 insider buys, and 10 selling transactions for $15.28 million activity. Shares for $188,080 were sold by SCHULER JACK W. $1.35M worth of Quidel Corporation (NASDAQ:QDEL) was sold by BORKAR RATAN S. Kroll Werner had sold 16,358 shares worth $661,529 on Friday, December 8. Bujarski Robert Joseph had sold 110,704 shares worth $4.40M. Shares for $1.46 million were sold by STEWARD RANDALL J.

The stock of Quidel Corporation (NASDAQ:QDEL) hit a new 52-week high and has $61.69 target or 8.00 % above today’s $57.12 share price. The 9 months bullish chart indicates low risk for the $2.13 billion company. The 1-year high was reported on Apr, 18 by Barchart.com. If the $61.69 price target is reached, the company will be worth $170.40 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 1.10% or $0.62 during the last trading session, reaching $57.12. About 83,125 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 128.16% since April 18, 2017 and is uptrending. It has outperformed by 116.61% the S&P500.

Analysts await Quidel Corporation (NASDAQ:QDEL) to report earnings on April, 23. They expect $0.92 EPS, up 119.05 % or $0.50 from last year’s $0.42 per share. QDEL’s profit will be $34.31M for 15.52 P/E if the $0.92 EPS becomes a reality. After $-0.11 actual EPS reported by Quidel Corporation for the previous quarter, Wall Street now forecasts -936.36 % EPS growth.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 8 analysts covering Quidel Corp (NASDAQ:QDEL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel Corp had 13 analyst reports since October 24, 2017 according to SRatingsIntel. William Blair maintained Quidel Corporation (NASDAQ:QDEL) on Friday, April 13 with “Buy” rating. The stock has “Buy” rating by Canaccord Genuity on Thursday, April 5. The stock of Quidel Corporation (NASDAQ:QDEL) has “Strong Buy” rating given on Thursday, March 8 by Raymond James. Canaccord Genuity maintained Quidel Corporation (NASDAQ:QDEL) on Tuesday, January 2 with “Buy” rating. The rating was upgraded by CL King to “Buy” on Thursday, January 4. The rating was initiated by Craig Hallum with “Buy” on Monday, March 26. The stock of Quidel Corporation (NASDAQ:QDEL) earned “Overweight” rating by Barclays Capital on Monday, April 2. Canaccord Genuity maintained it with “Buy” rating and $48.0 target in Tuesday, October 24 report. The rating was upgraded by C.L. King to “Buy” on Thursday, January 4. Barclays Capital maintained the shares of QDEL in report on Thursday, November 2 with “Overweight” rating.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC womenÂ’s and general health, and gastrointestinal diseases. The company has market cap of $2.13 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It currently has negative earnings. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.